P. Mao

发表

The catalytic, stem, and transmembrane portions of matriptase-2 are required for suppressing the expression of the iron-regulatory hormone hepcidin

C. Enns, An-Sheng Zhang, P. Mao, 2018, The Journal of Biological Chemistry.

Transcriptional activity by cocaine–amphetamine-regulated transcript

R. Jacks, P. Mao, 2007, Molecular Psychiatry.

The catalytic, stem, and transmembrane portions of matriptase-2 are required for suppressing the expression of the iron-regulatory hormone hepcidin

C. Enns, An-Sheng Zhang, P. Mao, 2018 .

New Insights into Estrogen Signaling

P. Mao, 2014 .

Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury.

N. Alkayed, D. Koop, D. Grant, 2006, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Polymorphisms in the Human Soluble Epoxide Hydrolase Gene EPHX2 Linked to Neuronal Survival after Ischemic Injury

N. Alkayed, D. Koop, D. Grant, 2007, The Journal of Neuroscience.

Toxicity of Neurons Treated with Herbicides and Neuroprotection by Mitochondria-Targeted Antioxidant SS31

P. Reddy, Byung S Park, M. Mańczak, 2011, International journal of environmental research and public health.

Granulocyte‐macrophage colony‐stimulating factor antibody suppresses microglial activity: implications for anti‐inflammatory effects in Alzheimer’s Disease and multiple sclerosis

M. Mańczak, Wei Zhao, G. Yarranton, 2009, Journal of neurochemistry.

Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage.

P. Hemachandra Reddy, P. Reddy, M. Mańczak, 2011, Human molecular genetics.

P. Reddy, M. Mańczak, M. Calkins, 2011, Brain Research Reviews.

Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics.

Vishwanath T. Anekonda, P. Reddy, M. Mańczak, 2012, Biochimica et biophysica acta.

Amyloid-beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive decline.

P. Reddy, M. Mańczak, M. Calkins, 2010, Journal of Alzheimer's disease : JAD.

Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics.

P. Reddy, P. Mao, P. H. Reddy, 2011, Biochimica et biophysica acta.

Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons.

P. Reddy, Byung S Park, M. Mańczak, 2010, Journal of Alzheimer's disease : JAD.

Is multiple sclerosis a mitochondrial disease?

P. Reddy, P. Reddy, P. Mao, 2009, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease.

Vishwanath T. Anekonda, P. Reddy, M. Mańczak, 2012, Human molecular genetics.

Recent Advances in Obesity: Genetics and Beyond

W. Cheung, P. Mao, 2012, ISRN endocrinology.

MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.

P. Reddy, M. Mańczak, P. Mao, 2013, Biochimica et biophysica acta.

Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease.

P. Reddy, M. Mańczak, M. Calkins, 2011, Human molecular genetics.

Neurotransmitter CART as a New Therapeutic Candidate for Parkinson’s Disease

P. Reddy, C. Meshul, P. Thuillier, 2013, Pharmaceuticals.

Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease.

P. Reddy, Byung S Park, M. Mańczak, 2009, Human molecular genetics.

Mitochondrial structural and functional dynamics in Huntington's disease

P. Reddy, M. Mańczak, P. Reddy, 2009, Brain Research Reviews.

A transgenic mouse model for Alzheimer's disease has impaired synaptic gain but normal synaptic dynamics

M. Frerking, P. Reddy, M. Mańczak, 2011, Neuroscience Letters.

Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension.

P. Rabinovitch, P. Reddy, M. Mańczak, 2012, Human molecular genetics.

Oxidative Stress and Its Clinical Applications in Dementia

P. Mao, 2012, Journal of neurodegenerative diseases.

Potential Antidepressant Role of Neurotransmitter CART: Implications for Mental Disorders

P. Mao, 2011, Depression research and treatment.

Neuropeptide cocaine- and amphetamine-regulated transcript usage in Parkinson's disease

P. Mao, Y. Mao, 2020 .

Mitochondrial mechanism of neuroprotection by CART

Sufang Yang, N. Alkayed, P. Hurn, 2007, The European journal of neuroscience.

CART Peptide Is a Potential Endogenous Antioxidant and Preferentially Localized in Mitochondria

P. Reddy, C. Meshul, P. Thuillier, 2012, PloS one.

Mitochondrial DNA deletions and differential mitochondrial DNA content in Rhesus monkeys: implications for aging.

P. Reddy, Byung S Park, M. Mańczak, 2012, Biochimica et biophysica acta.

Research resource: Gene profiling of G protein-coupled receptors in the arcuate nucleus of the female.

O. Rønnekleiv, M. Kelly, Chunguang Zhang, 2014, Molecular endocrinology.

Recent progress and concerns in dementia: Distinguishing Alzheimer's disease and dementia with Lewy bodies via biochemical markers in the cerebrospinal fluid

P. Mao, 2012 .

Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease.

Vishwanath T. Anekonda, P. Reddy, M. Mańczak, 2012, Human molecular genetics.

M. Mańczak, M. Calkins, P. Reddy, 2011, Brain Research Reviews.

Mitochondrial structural and functional dynamics in Huntington's disease

M. Mańczak, P. Mao, P. Hemachandra Reddy, 2009, Brain Research Reviews.

MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.

M. Mańczak, P. Mao, U. Shirendeb, 2013, Biochimica et biophysica acta.